VHL mutations in renal cell cancer: Does occupational exposure to trichloroethylene make a difference?

Toxicology Letters

Volumn 151, Issue 1, 2004, Pages 301-310

  Brauch, Hiltrud ^a   Weirich, Gregor ^b   Klein, Bettina ^a   Rabstein, Sylvia ^c   Bolt, Hermann M ^d   Brüning, Thomas ^c,d  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Inst F Arbeitsphysiologie An U   (Germany)

Author keywords

Occupational exposure; Renal cell cancer risk; Somatic mutations; Trichloroethylene (TCE); VHL

Indexed keywords

TRICHLOROETHYLENE; VON HIPPEL LINDAU PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE MUTATION; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CANCER; MALE; MUTATIONAL ANALYSIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 2942516224     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.12.074     Document Type: Article

References (39)

1. Ben-Ezra J., Johnson D.A., Rossi J., Cook N., Wu A. Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J. Histochem. Cytochem. 39:1991;351-354
2. Brauch H., Weirich G., Hornauer M.A., Storkel S., Wohl T., Brüning T. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J. Natl. Cancer Inst. 91:1999;854-861
3. Brauch H., Weirich G., Brieger J., Glavac D., Rodl H., Eichinger M., Feurer M., Weidt E., Puranakanitstha C., Neuhaus C., Pomer S., Brenner W., Schirmacher P., Storkel S., Rotter M., Masera A., Gugeler N., Decker H.J. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Cancer Res. 60:2000;1942-1948
4. Brüning T., Bolt H.M. Renal toxicity and carcinogenicity of trichloroethylene: key results, mechanisms, and controversies. Crit. Rev. Toxicol. 30:2000;253-285
5. Brüning T., Pesch B., Wiesenhutter B., Rabstein S., Lammert M., Baumuller A., Bolt H.M. Renal cell cancer risk and occupational exposure to trichloroethylene: Results of a consecutive case-control study in Arnsberg, Germany. Am. J. Ind. Med. 43:2003;274-285
6. Cherrie J.W., Kromhout H., Semple S. The importance of reliable exposure estimates in deciding whether trichloroethylene can cause kidney cancer. J. Cancer Res. Clin. Oncol. 127:2001;400-404
7. Cohen A.J., Li F.P., Berg S., Marchetto D.J., Tsai S., Jacobs S.C., Brown R.S. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med. 301:1979;592-596
8. DFG, 1996. Trichlorethen. In: Greim, H., Henschler, D. (Eds.), Gesundheitsschädliche Arbeitsstoffe. Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten. VCH-Verlagsgesellschaft, Weinheim, pp. 1-43 (T).
9. Dhote R., Pellicer-Coeuret M., Thiounn N., Debre B., Vidal-Trecan G. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int. 86:2000;20-27
10. Dosemeci M., Cocco P., Chow W.H. Gender differences in risk of renal cell carcinoma and occupational exposures to chlorinated aliphatic hydrocarbons. Am. J. Ind. Med. 36:1999;54-59
11. Foster K., Prowse A., van den Berg A., Fleming S., Hulsbeek M.M., Crossey P.A., Richards F.M., Cairns P., Affara N.A., Ferguson-Smith M.A., et al. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum. Mol. Genet. 3:1994;2169-2173
12. Frayling I.M. Methods of molecular analysis: mutation detection in solid tumours. Mol. Pathol. 55:2002;73-79
13. Glavac D., Neumann H.P., Wittke C., Jaenig H., Masek O., Streicher T., Pausch F., Engelhardt D., Plate K.H., Hofler H., Chen F., Zbar B., Brauch H. Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum. Genet. 98:1996;271-280
14. Gnarra J.R., Tory K., Weng Y., Schmidt L., Wei M.H., Li H., Latif F., Liu S., Chen F., Duh F.M., et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet. 7:1994;85-90
15. Green L.C., Lash T.L. Reply to "Renal cell cancer correlated with occupational exposure to trichloroethylene" J. Cancer Res. Clin. Oncol. 125:1999;430-432
16. Hansen J. Breast cancer risk among relatively young women employed in solvent-using industries. Am. J. Ind. Med. 36:1999;43-47
17. Henschler D., Vamvakas S., Lammert M., Dekant W., Kraus B., Thomas B., Ulm K. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethene. Arch. Toxicol. 69:1995;291-299
18. Hes F.J., McKee S., Taphoorn M.J., Rehal P., van der Luijt R.B., McMahon R., van der Smagt J.J., Dow D., Zewald R.A., Whittaker J., Lips C.J., MacDonald F., Pearson P.L., Maher E.R. Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only. J. Med. Genet. 37:2000;939-943
19. IARC, 1995. Trichloroethylene. In: International Agency for Research on Cancer, Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. IARC, Lyon, pp. 75-158 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 63).
20. Kenck C., Wilhelm M., Bugert P., Staehler G., Kovacs G. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas. J. Pathol. 179:1996;157-161
21. Linehan, W.M., Shipley, W.U., Parkinson, D.R., 1997. Renal carcinoma. In: Devita, V.T., Hellman, S., Rosenberg, S.A. (Eds.), Cancer: Principles and Practice of Oncology, fifth ed. Lippincott Willians & Wilkins, Philadelphia, pp. 1271-1280.
22. Mandel J.S. Renal cell cancer correlated with occupational exposure to trichloroethylene. J. Cancer Res. Clin. Oncol. 127:2001;265-268
23. Mandel J.S., McLaughlin J.K., Schlehofer B., Mellemgaard A., Helmert U., Lindblad P., McCredie M., Adami H.O. International renal-cell cancer study. IV. Occup. Int. J. Cancer. 61:1995;601-605
24. Moyad M.A. Review of potential risk factors for kidney (renal cell) cancer. Semin. Urol. Oncol. 19:2001;280-293
25. Pesch B., Haerting J., Ranft U., Klimpel A., Oelschlagel B., Schill W. Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. Int. J. Epidemiol. 29:2000;1014-1024
26. Rego M.A., Sousa C.S., Kato M., de Carvalho A.B., Loomis D., Carvalho F.M. Non-Hodgkin's lymphomas and organic solvents. J. Occup. Environ. Med. 44:2002;874-881
27. Ruden C. The use and evaluation of primary data in 29 trichloroethylene carcinogen risk assessments. Regul. Toxicol. Pharmacol. 34:2001;3-16
28. Shuin T., Kondo K., Torigoe S., Kishida T., Kubota Y., Hosaka M., Nagashima Y., Kitamura H., Latif F., Zbar B., et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 54:1994;2852-2855
29. Vamvakas S., Brüning T., Thomasson B., Lammert M., Baumuller A., Bolt H.M., Dekant W., Birner G., Henschler D., Ulm K. Renal cell cancer correlated with occupational exposure to trichloroethene. J. Cancer Res. Clin. Oncol. 124:1998;374-382
30. Vamvakas S., Brüning T., Bolt H.M., Henschler D., Ulm K. Renal cell cancer correlated with occupational exposure to trichloroethene. J. Cancer Res. Clin. Oncol. 126:2000;178-180
31. Vamvakas S., Brüning T., Bolt H.M., Henschler D., Ulm K. Renal cell cancer correlated with occupational exposure to trichloroethylene. J. Cancer Res. Clin. Oncol. 127:2001a;267-268
32. Vamvakas S., Brüning T., Bolt H.M., Henschler D., Ulm K. Exposure estimates in studies on workplace exposures to trichlolorethylene in relation to renal cell cancer formation (reply). J. Cancer Res. Clin. Oncol. 127:2001b;403-404
33. Wartenberg D., Scott C.S. Carcinogenicity of trichloroethylene. Environ. Health Perspect. 110:2002;A13-A14
34. Wartenberg D., Reyner D., Scott C.S. Trichloroethylene and cancer: epidemiologic evidence. Environ. Health Perspect. 108(Suppl. 2):2000;161-176
35. Weirich G., Klein B., Wohl T., Engelhardt D., Brauch H. VHL2C phenotype in a German von Hippel-Lindau family with concurrent VHL germline mutations P81S and L188V. J. Clin. Endocrinol. Metab. 87:2002;5241-5246
36. Whaley J.M., Naglich J., Gelbert L., Hsia Y.E., Lamiell J.M., Green J.S., Collins D., Neumann H.P., Laidlaw J., Li F.P., et al. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am. J. Hum. Genet. 55:1995;1092-1102. (published erratum appears in Am. J. Hum. Genet. 56, 356 (1995))
37. Wiedorn K.H., Olert J., Stacy R.A., Goldmann T., Kuhl H., Matthus J., Vollmer E., Bosse A. HOPE - a new fixing technique enables preservation and extraction of high molecular weight DNA and RNA of >20 kb from paraffin-embedded tissues. Hepes-Glutamic acid buffer mediated organic solvent protection effect. Pathol. Res. Pract. 198:2002;735-740
38. Wiegand P., Domhover J., Brinkmann B. DNA degradation in formalin fixed tissues (in German). Pathologe. 17:1996;451-454
39. Williams C., Ponten F., Moberg C., Soderkvist P., Uhlen M., Ponten J., Sitbon G., Lundeberg J. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am. J. Pathol. 155:1999;1467-1471